Viemed Healthcare, Inc. (a Bristol Investor Relations client) announced that it has reported its financial results for the three and nine months ended September 30, 2022. Operational highlights include that net revenues attributable to the company’s core business for the quarter ended September 30, 2022 were $35.8 million, a new company record, and an increase of $7.9 million, or 28%, over core net revenues reported for the comparable quarter ended September 30, 2021. This represents 7% sequential growth in core revenue over the quarter ended June 30, 2022. The impressive third quarter financial results reflect robust growth and the team’s disciplined execution of strategy, according to Casey Hoyt, Viemed’s CEO. Viemed Healthcare, Inc. is a national leader in respiratory care and technology-enabled home medical equipment services.

Read the full press relelase here: Viemed Healthcare Announces Third Quarter 2022 Financial Results